AstraZeneca: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
AstraZeneca
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€8.6m
2024 · €8.2m+€455,885
Equity
€46.9m
2024 · €38.2m+€8.6m
Cash
€1.5m
2024 · €752,524+€723,392
Balance sheet total
€105.4m
2024 · €88.0m+€17.3m
Largest movements
Assets
- Receivables within one year +€14.2m
up €14.2m (+16.5%), from €86.2m to €100.4m
of which Other amounts receivable: +€9.9m
- Tangible fixed assets +€2.7m
up €2.7m (+3519.6%), from €78,063 to €2.8m
of which Assets under construction and advance payments: +€1.6m
Equity and liabilities
- Trade debts +€8.9m
up €8.9m (+23.1%), from €38.5m to €47.4m
- Profit (loss) carried forward +€8.6m
up €8.6m (+97.6%), from €8.9m to €17.5m
Income statement
- Turnover +€33.7m
up €33.7m (+10.6%), from €317.5m to €351.2m
- Other operating charges +€17.4m
up €17.4m (+13.8%), from €126.2m to €143.6m
- Services and other goods +€7.5m
up €7.5m (+23.8%), from €31.5m to €39.0m
- Goods and materials +€4.9m
up €4.9m (+3.7%), from €132.6m to €137.5m
- Staff costs +€4.0m
up €4.0m (+10.2%), from €39.6m to €43.7m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€8.2m
Turnover
+€33.7m
Other operating income
+€3.5m
Goods and materials
-€4.9m
Services and other goods
-€7.5m
Staff costs
-€4.0m
Depreciation
-€124,839
Other operating charges
-€17.4m
Other operating items
-€164,859
Financial income
-€2.4m
Financial charges
-€31,401
Taxes
-€290,848
Result 2025
€8.6m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€3.6m
Investment
-€2.9m
Financing
€0
Cash 2024
€752,524
From operations (derived)
+€3.6m
Net result for the year
+€8.6m
Depreciation
+€149,184
Receivables within one year
-€14.2m
Deferred charges and accrued income
+€384,898
Trade debts
+€8.9m
Tax, wage and social debts
-€188,292
Investment (derived)
-€2.9m
Investment in fixed assets (net)
-€2.9m
Cash 2025
€1.5m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €88,045,837 | €105,380,930 | +€17.3m | +19.7% |
| Fixed assets | 21/28 | €78,063 | €2,825,569 | +€2.7m | +3519.6% |
| Tangible fixed assets | 22/27 | €78,063 | €2,825,569 | +€2.7m | +3519.6% |
| Plant, machinery and equipment | 23 | €0 | €1,024,085 | +€1.0m | |
| Furniture and vehicles | 24 | €46,023 | €63,865 | +€17,842 | +38.8% |
| Other tangible fixed assets | 26 | €32,041 | €176,586 | +€144,546 | +451.1% |
| Assets under construction and advance payments | 27 | - | €1,561,032 | +€1.6m | |
| Current assets | 29/58 | €87,967,774 | €102,555,361 | +€14.6m | +16.6% |
| Stocks and contracts in progress | 3 | €0 | €0 | = | |
| Amounts receivable within one year | 40/41 | €86,172,679 | €100,421,772 | +€14.2m | +16.5% |
| Trade receivables | 40 | €49,208,275 | €53,593,398 | +€4.4m | +8.9% |
| Other amounts receivable | 41 | €36,964,404 | €46,828,373 | +€9.9m | +26.7% |
| Cash at bank and in hand | 54/58 | €752,524 | €1,475,916 | +€723,392 | +96.1% |
| Deferred charges and accrued income | 490/1 | €1,042,571 | €657,674 | -€384,898 | -36.9% |
| Total equity and liabilities | 10/49 | €88,045,837 | €105,380,930 | +€17.3m | +19.7% |
| Equity | 10/15 | €38,233,378 | €46,880,546 | +€8.6m | +22.6% |
| Contributions | 10/11 | €26,583,725 | €26,583,725 | = | 0.0% |
| Capital | 10 | €22,000,000 | €22,000,000 | = | 0.0% |
| Issued capital | 100 | €22,000,000 | €22,000,000 | = | 0.0% |
| Outside capital | 11 | €4,583,725 | €4,583,725 | = | 0.0% |
| Share premium | 1100/10 | €4,583,725 | €4,583,725 | = | 0.0% |
| Reserves | 13 | €2,788,501 | €2,788,501 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,232,276 | €2,232,276 | = | 0.0% |
| Legal reserve | 130 | €2,200,000 | €2,200,000 | = | 0.0% |
| Other | 1319 | €32,276 | €32,276 | = | 0.0% |
| Tax-exempt reserves | 132 | €556,226 | €556,226 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,861,151 | €17,508,319 | +€8.6m | +97.6% |
| Provisions and deferred taxes | 16 | €0 | €0 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €0 | €0 | = | 0.0% |
| Pensions and similar obligations | 160 | €0 | €0 | = | 0.0% |
| Amounts payable | 17/49 | €49,812,460 | €58,500,385 | +€8.7m | +17.4% |
| Amounts payable within one year | 42/48 | €49,812,460 | €58,500,385 | +€8.7m | +17.4% |
| Trade debts | 44 | €38,503,582 | €47,379,799 | +€8.9m | +23.1% |
| Suppliers | 440/4 | €38,503,582 | €47,379,799 | +€8.9m | +23.1% |
| Taxes, remuneration and social security | 45 | €11,308,878 | €11,120,585 | -€188,292 | -1.7% |
| Taxes | 450/3 | €2,175,339 | €2,406,443 | +€231,105 | +10.6% |
| Remuneration and social security | 454/9 | €9,133,539 | €8,714,142 | -€419,397 | -4.6% |
| Other amounts payable | 47/48 | €0 | - | = | |
| Operating income | 70/76A | €338,788,721 | €375,913,958 | +€37.1m | +11.0% |
| Turnover | 70 | €317,480,461 | €351,224,744 | +€33.7m | +10.6% |
| Other operating income | 74 | €21,143,367 | €24,689,214 | +€3.5m | +16.8% |
| Non-recurring operating income | 76A | €164,893 | €0 | -€164,893 | -100.0% |
| Operating charges | 60/66A | €329,947,006 | €363,928,829 | +€34.0m | +10.3% |
| Goods for resale, raw materials and consumables | 60 | €132,585,454 | €137,521,865 | +€4.9m | +3.7% |
| Purchases | 600/8 | €132,585,454 | €137,521,865 | +€4.9m | +3.7% |
| Services and other goods | 61 | €31,540,269 | €39,035,788 | +€7.5m | +23.8% |
| Remuneration, social security and pensions | 62 | €39,620,683 | €43,661,410 | +€4.0m | +10.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,345 | €149,184 | +€124,839 | +512.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €0 | - | = | |
| Other operating charges | 640/8 | €126,176,221 | €143,560,583 | +€17.4m | +13.8% |
| Non-recurring operating charges | 66A | €33 | €0 | -€33 | -100.0% |
| Operating profit (loss) | 9901 | €8,841,715 | €11,985,129 | +€3.1m | +35.6% |
| Financial income | 75/76B | €3,015,466 | €650,186 | -€2.4m | -78.4% |
| Recurring financial income | 75 | €3,015,466 | €650,186 | -€2.4m | -78.4% |
| Income from current assets | 751 | €3,008,814 | €634,283 | -€2.4m | -78.9% |
| Other financial income | 752/9 | €6,652 | €15,904 | +€9,252 | +139.1% |
| Financial charges | 65/66B | €719,492 | €750,893 | +€31,401 | +4.4% |
| Recurring financial charges | 65 | €719,492 | €750,893 | +€31,401 | +4.4% |
| Debt charges | 650 | €443,008 | €449,913 | +€6,905 | +1.6% |
| Other financial charges | 652/9 | €276,484 | €300,980 | +€24,496 | +8.9% |
| Profit (loss) for the period before taxes | 9903 | €11,137,689 | €11,884,422 | +€746,733 | +6.7% |
| Income taxes | 67/77 | €2,946,406 | €3,237,254 | +€290,848 | +9.9% |
| Taxes | 670/3 | €2,946,406 | €3,237,254 | +€290,848 | +9.9% |
| Profit (loss) for the period | 9904 | €8,191,283 | €8,647,168 | +€455,885 | +5.6% |
| Profit (loss) for the period to be appropriated | 9905 | €8,191,283 | €8,647,168 | +€455,885 | +5.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.